Kristin Yarema - Net Worth and Insider Trading
Kristin Yarema Net Worth
The estimated net worth of Kristin Yarema is at least $51,760 dollars as of 2024-11-05. Kristin Yarema is the Chief Commercial Officer of Atara Biotherapeutics Inc and owns about 5,035 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $51,760. Details can be seen in Kristin Yarema's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kristin Yarema has not made any transactions after 2021-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kristin Yarema
Kristin Yarema Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kristin Yarema owns 2 companies in total, including Atara Biotherapeutics Inc (ATRA) , and Poseida Therapeutics Inc (PSTX) .
Click here to see the complete history of Kristin Yarema’s form 4 insider trades.
Insider Ownership Summary of Kristin Yarema
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2022-03-01 | Chief Commercial Officer |
| PSTX | Poseida Therapeutics Inc | 2023-04-11 | President & Cell Therapy |
Kristin Yarema Latest Holdings Summary
Kristin Yarema currently owns a total of 1 stock. Kristin Yarema owns 5,035 shares of Atara Biotherapeutics Inc (ATRA) as of June 14, 2021, with a value of $51,760.
Latest Holdings of Kristin Yarema
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2021-06-14 | 5,035 | 10.28 | 51,760 |
Holding Weightings of Kristin Yarema
Kristin Yarema Form 4 Trading Tracker
According to the SEC Form 4 filings, Kristin Yarema has made a total of 2 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 1,374 shares on June 14, 2021, which cost Kristin Yarema around $500,538.
Insider Trading History of Kristin Yarema
- 1
Kristin Yarema Trading Performance
GuruFocus tracks the stock performance after each of Kristin Yarema's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kristin Yarema is 6.82%. GuruFocus also compares Kristin Yarema's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kristin Yarema within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kristin Yarema's insider trading performs compared to the benchmark.
Performance of Kristin Yarema
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.64 | | | | | |
| Relative Return to S&P 500(%) | -10.44 | | | | | |
Kristin Yarema Ownership Network
Ownership Network List of Kristin Yarema
Ownership Network Relation of Kristin Yarema
Kristin Yarema Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Kristin Yarema is the Chief Commercial Officer of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Kristin Yarema made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Kristin Yarema Mailing Address
Above is the net worth, insider trading, and ownership report for Kristin Yarema. You might contact Kristin Yarema via mailing address: C/o Atara Biotherapeutics, Inc., 611 Gateway Blvd., Suite 900, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
